Head to head for first-timers
CoreAge Rx vs SkinnyRx
CoreAge Rx and SkinnyRx both offer GLP-1 telehealth, but they make different trade-offs on how gentle the start is, honest pricing, real support and access. Here they are side by side on the Mama-Match Score — our first-timer rubric.
CoreAge Rx
Higher scoreRank #1 for first-timers · Grade A
Mama-Match
Best for: Moms who want a clear, honest first step — a real clinician instead of a questionnaire, a flat price, and the freedom to pause when life needs you to.
Visit CoreAge RxSkinnyRx
Rank #93 for first-timers · Grade C
Mama-Match
Best for: Moms willing to verify SkinnyRx's compounding and ingredient claims for themselves rather than take its labels or marketing at face value — the FDA found the site misrepresents who actually compounds these products and implies an FDA-approved status they don't have. Read the FDA's letter before you weigh in the tablet option or the flat pricing.
Visit SkinnyRxThe verdict for a first step
CoreAge Rx edges out SkinnyRx on the Mama-Match Score, 94 to 48 (A vs C). Moms who want a clear, honest first step — a real clinician instead of a questionnaire, a flat price, and the freedom to pause when life needs you to.
SkinnyRx is still a genuine option — a flat $199/mo semaglutide, $299/mo tirzepatide, with an option most of this batch skips: a sublingual tablet instead of a weekly shot — but the FDA issued its parent entity, Lean Rx, Inc., a warning letter on 02/20/2026 (ref. 717989) for mislabeling itself as the compounder on its own product images and for marketing language implying its compounded products share FDA-approved status with Mounjaro and Zepbound, which they don't. Confirmed directly on FDA.gov; SkinnyRx's own site never mentions it. Weigh the six first-timer factors below against your own priorities.
Side by side on all six factors
Both providers judged on the same first-timer rubric — the higher side on each factor is marked. See the methodology.
Price, access and features
| Detail | CoreAge Rx | SkinnyRx |
|---|---|---|
| Mama-Match Score | 94/100 · A | 48/100 · C |
| Overall rank | #1 | #93 |
| Semaglutide | $99/mo | $199/mo |
| Tirzepatide | $149/mo | $299/mo |
| Coverage | All 50 states | Not disclosed on the public site we reviewed |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Yes |
Mama-Match
CoreAge Rx
Rank #1 · Grade A
What we like
- One flat monthly price, with no teaser rate that jumps after the first month — you know the number before you commit
- A clinician reads your history and will genuinely talk timing with you if you're postpartum, breastfeeding, or trying to conceive
- Semaglutide and tirzepatide in one account, so you and a clinician can choose — and switch — without starting over
The caveats
- Not the rock-bottom teaser price — a couple of marketplaces dangle a lower first-month number
- Compounded medication only, not FDA-approved brand-name Ozempic or Wegovy
- A general metabolic program, not a dedicated OB-GYN or hormone consult
Mama-Match
SkinnyRx
Rank #93 · Grade C
What we like
- Offers sublingual tablets as a genuine alternative to injections for both molecules
- Flat pricing regardless of dose
- Internal site code carries a "no_membership" flag consistent with no separate fee
The caveats
- No state list published anywhere on the public site
- Pricing only surfaces in compiled app data, not a plain page read
- Nothing maternal-specific — general telehealth framing
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Mama-Match Score. Prices, states and verification reflect what each provider disclosed publicly at our last review; the Mama-Match Score is our editorial judgment under the methodology. Prices change — confirm them on each provider’s site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing CoreAge Rx and SkinnyRx with the other providers we review for women.
Or browse the full comparison hub.